FAKTOR-OPTIONSSCHEIN - HALEON Share Price

Certificat

DE000MG1K2U7

Market Closed - Börse Stuttgart 07:36:05 24/05/2024 pm IST
10.31 EUR +6.51% Intraday chart for FAKTOR-OPTIONSSCHEIN - HALEON
Current month+9.56%
1 month+1.08%
Date Price Change
24/24/24 10.31 +6.51%
23/24/23 9.68 -3.01%
22/24/22 9.98 +2.46%
21/24/21 9.74 +2.85%
20/24/20 9.47 -3.86%

Delayed Quote Börse Stuttgart

Last update May 24, 2024 at 07:36 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying HALEON PLC
Issuer Morgan Stanley
WKN MG1K2U
ISINDE000MG1K2U7
Date issued 03/04/2024
Strike 438.5 p
Maturity Unlimited
Parity 0.13 : 1
Emission price 10
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 11.19
Lowest since issue 9.26
Spread 0.03
Spread %0.28%

Company Profile

Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Sector
-
More about the company

Ratings for Haleon plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Haleon plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
3.23 GBP
Average target price
3.62 GBP
Spread / Average Target
+12.07%
Consensus